Variables | Control (n = 301) | Intervention (n = 300) | Total (n = 601) | p |
---|---|---|---|---|
Gender, n (%) | ||||
Female | 190 (63.1) | 199 (66.3) | 389 (64.7) | 0.410 |
Male | 111 (36.9) | 101 (36.7) | 212 (35.3) | |
Age (years), mean (SD) | 75.77 (7.44) | 74.57 (7.01) | 75.10 (7.25) | 0.373 |
65–74 | 147 (48.8) | 158 (52.7) | 305 (50.7) | 0.193 |
75–84 | 113 (37.5) | 115 (38.3) | 228 (37.9) | |
≥85 | 41 (13.6) | 27 (9.0) | 68 (11.3) | |
Weight (kg), mean (SD) | 75.91 (15.23) | 76.74 (14.94) | 76.37 (15.06) | 0.594 |
Height (cm), mean (SD) | 162.16 (8.52) | 160.56 (9.20) | 161.27 (8.93) | 0.034* |
BMI (kg/m2), mean (SD) | 30.33 (6.42) | 29.89 (5.91) | 30.09 (6.97) | 0.205 |
Marital status, n (%) | ||||
Married | 184 (61.1) | 185 (61.7) | 369 (61.4) | 0.012* |
Divorced | 112 (37.2) | 97 (32.3) | 209 (34.8) | |
Widowed | 5 (1.7) | 18 (6.0) | 23 (3.8) | |
Number of children, median (range) | 3 (0–9) | 4 (0–9) | 3 (0–9) | 0.881 |
Smoking, n (%) | 69 (22.9) | 71 (23.7) | 140 (23.3) | 0.829 |
Alcohol, n (%) | 5 (1.7) | 9 (3.0) | 14 (2.3) | 0.414 |
Allergy, n (%) | 5 (1.7) | 10 (3.3) | 15 (2.5) | 0.293 |
Fall within the last year, n (%) | 77 (25.6) | 94 (31.3) | 171 (28.5) | 0.118 |
Influenza vaccination, n (%) | 40 (13.3) | 48 (16.0) | 88 (14.6) | 0.347 |
Pneumococcal vaccination, n (%) | 71 (23.6) | 73 (24.3) | 144 (24.0) | 0.831 |
Forgetfulness, n (%) | 167 (60.5) | 177 (59.0) | 344 (59.7) | 0.713 |
Progressive forgetfulness, n (%) | 108 (39.3) | 106 (35.3) | 214 (37.2) | 0.329 |
Diagnosis, n (%) | ||||
Hypertension | 233 (77.4) | 246 (82.0) | 479 (79.7) | 0.162 |
Diabetes mellitus | 151 (50.2) | 148 (49.3) | 299 (49.8) | 0.838 |
Coronary artery disease | 122 (40.5) | 111 (37.0) | 233 (38.8) | 0.374 |
Hypothyroidism | 43 (14.3) | 35 (11.7) | 78 (13.0) | 0.339 |
Atrial fibrillation | 48 (15.9) | 28 (9.3) | 76 (12.6) | 0.015* |
Osteoporosis | 42 (14.0) | 33 (11.0) | 75 (12.5) | 0.273 |
Asthma | 42 (14.0) | 33 (11.0) | 75 (12.5) | 0.273 |
Congestive heart failure | 36 (12.0) | 34 (11.3) | 70 (11.6) | 0.811 |
Chronic kidney disease | 33 (11.0) | 27 (9.0) | 60 (10.0) | 0.422 |
COPD | 30 (10.0) | 21 (7.0) | 51 (8.5) | 0.247 |
Acute renal failure | 19 (6.3) | 10 (3.3) | 29 (4.8) | 0.130 |
Liver failure | 3 (1.0) | 2 (0.7) | 5 (0.8) | 1.000 |
CCI, mean (SD) | 6.01 (2.90) | 5.50 (2.32) | 5.75 (2.61) | 0.559 |
ADLs (n = 547), mean (SD) | 5.02 (1.68) | 5.21 (1.43) | 5.12 (1.55) | 0.938 |
IADLs (n = 543), mean (SD) | 5.92 (2.88) | 6.17 (2.74) | 6.05 (2.81) | 0.891 |
MNA-SF (n = 428), mean (SD) | 11.59 (3.06) | 11.41 (3.52) | 11.49 (3.31) | 0.996 |
GDS (n = 454), mean (SD) | 4.79 (4.33) | 4.18 (3.96) | 4.47 (4.15) | 0.633 |
MMSE (n = 508), mean (SD) | 25.99 (5.78) | 25.43 (6.36) | 25.71 (6.08) | 0.379 |
CDT (n = 443), mean (SD) | 3.85 (2.39) | 3.71 (2.50) | 3.78 (2.45) | 0.968 |